(Q43640822)

25 November 2017

title

A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis (English)

1 reference

25 November 2017

1 reference

Briscoe RJ

1

1 reference

25 November 2017

Jeanville PM

2

1 reference

25 November 2017

Cabrera C

3

1 reference

25 November 2017

Baird TJ

4

1 reference

25 November 2017

Woods JH

5

1 reference

25 November 2017

Landry DW

6

1 reference

25 November 2017

language of work or name

1 reference

1 June 2001

1 reference

International Immunopharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

1

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

1189-1198

1 reference

Clinical pharmacology and toxicology of cocaine

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Cocaine-induced cardiovascular responses in rats during acute ethanol withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Drugs of abuse and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Cocaine-enhanced arrhythmogenesis: neural and nonneural mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Antibody-catalyzed degradation of cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Peripheral cocaine-blocking agents: new medications for cocaine dependence. An introduction to immunological and enzymatic approaches to treating cocaine dependence reported by Fox, Gorelick and Cohen in the immediately succeeding articles (see page

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

A potential vaccine for cocaine abuse prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Efficacy of a therapeutic cocaine vaccine in rodent models.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Chronic vascular catheterization in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Suppression of psychoactive effects of cocaine by active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Methadone: where are we now?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900054-6

7 January 2021

10.1016/S1567-5769(01)00054-6

Identifiers

DOI

1 reference

25 November 2017

1 reference